Tecan Group AG (LON: 0QLN)
London
· Delayed Price · Currency is GBP · Price in CHF 231.80
+2.40 (1.05%)
Jan 23, 2025, 1:44 PM BST
Tecan Group AG Revenue
Tecan Group AG had revenue of 467.16M CHF in the half year ending June 30, 2024, a decrease of -20.01%. This brings the company's revenue in the last twelve months to 1.00B, down -9.23% year-over-year. In the year 2023, Tecan Group AG had annual revenue of 1.07B, down -6.11%.
Revenue (ttm)
1.00B CHF
Revenue Growth
-9.23%
P/S Ratio
n/a
Revenue / Employee
279.89K CHF
Employees
3,573
Market Cap
2.61B GBP
Revenue Chart
* This company reports financials in CHF.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 1.07B | -69.88M | -6.11% |
| Dec 31, 2022 | 1.14B | 197.64M | 20.88% |
| Dec 31, 2021 | 946.62M | 215.74M | 29.52% |
| Dec 31, 2020 | 730.88M | 94.06M | 14.77% |
| Dec 31, 2019 | 636.82M | 43.02M | 7.25% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| GSK plc | 31.31B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| ConvaTec Group | 1.74B |
| Hikma Pharmaceuticals | 2.39B |
| HUTCHMED (China) | 483.31M |
| Oxford Nanopore Technologies | 167.75M |
Tecan Group AG News
- 5 months ago - Tecan Group AG (TCHBF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 11 months ago - Tecan Group AG (TCHBF) Q4 2023 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Tecan Group AG (TCHBF) Q2 2023 Earnings Call Transcript - Seeking Alpha
- 2 years ago - Tecan Group AG (TCHBF) Q4 2022 Earnings Call Transcript - Seeking Alpha